H
HCW Biologics Inc. (HCWB)
NCM – Real vaqt narxi. Valyuta: USD
3.11
-0.06 (-1.89%)
Bozor ochiq: Aug 12, 2026, 2:21 PM EDT
3.17
0.00 (0.00%)
Oldingi bozordan keyin: Aug 11, 2026, 4:47 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
3.11
-0.06 (-1.89%)
Bozor ochiq: Aug 12, 2026, 2:21 PM EDT
3.17
0.00 (0.00%)
Oldingi bozordan keyin: Aug 11, 2026, 4:47 PM EDT
HCW Biologics Inc., klinik bosqichdagi biofarmatsevtika kompaniyasi, AQShda surunkali, kam darajali yallig'lanish va kasalliklar uchun yangi immunoterapiyalarni kashf qilish va ishlab chiqishga qaratilgan. Uning asosiy mahsulotlari orasida HCW11-018b, yangi, tetravalent T-hujayra ingeneri; HCW11-040, sitokinlar va pembrolizumabning kombinatsiyasi bo'lgan ko'p funksiyali termoyadroviy molekula; va HCW9302, in'ektsiya qilinadigan va interleukin 2 (IL-2) termoyadroviy oqsil kompleksi, bu soch to'kilishi kasalliklari bo'lgan bemorlarda klinik sinovdan o'tmoqda. Kompaniya, shuningdek, tabiiy killer (NK) hujayralariga asoslangan terapiyalarni ishlab chiqarishda reagent sifatida ishlatiladigan termoyadroviy oqsil HCW9201; yuqumli kasalliklarni davolash uchun CAR-terapiyalarni ishlab chiqarishda reagent sifatida ishlatiladigan termoyadroviy oqsil HCW9206; va ko'p funksiyali immunitet hujayralari stimulyatori HCW11-006ni ishlab chiqadi. U Wugen Inc. bilan hujayra terapiyasiga asoslangan davolash usullarini ishlab chiqish bo'yicha litsenzion kelishuvga ega; va WY Biotech Co., Ltd. bilan uning preklinik molekulasi uchun litsenziya, tadqiqot va birgalikda ishlab chiqish to'g'risidagi kelishuvga ega. HCW Biologics Inc. 2018 yilda tashkil etilgan va Floridadagi Miramar shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Hing C. Wong Ph.D. | Founder, CEO, Director & Secretary |
| Dr. Peter Rhode Ph.D. | Chief Scientific Officer & VP of Clinical Operations |
| Mr. Lee D. Flowers | Senior Vice President of Business Development |
| Ms. Nicole Valdivieso Esq., J.D. | Vice President of Legal Affairs |
| Ms. Rebecca Byam CPA, M.B.A. | Chief Financial Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-08-06 | D | |
| 2026-07-29 | 8-K | form8-k.htm |
| 2026-07-16 | POS AM | formposam.htm |
| 2026-07-01 | 8-K | form8-k.htm |
| 2026-06-30 | 8-K | form8-k.htm |
| 2026-06-26 | 8-K | form8-k.htm |
| 2026-06-18 | S-1/A | forms-1a.htm |
| 2026-06-16 | 8-K | form8-k.htm |
| 2026-06-15 | 8-K | form8-k.htm |
| 2026-06-08 | S-1 | forms-1.htm |